Rocher, G.; Gaillard, T.; Uzan, C.; Collinet, P.; Bolze, P.-A.; Ballester, M.; Bendifallah, S.; Ouldamer, L.; Touboul, C.; Huchon, C.;
et al. Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group. J. Clin. Med. 2021, 10, 1058.
https://doi.org/10.3390/jcm10051058
AMA Style
Rocher G, Gaillard T, Uzan C, Collinet P, Bolze P-A, Ballester M, Bendifallah S, Ouldamer L, Touboul C, Huchon C,
et al. Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group. Journal of Clinical Medicine. 2021; 10(5):1058.
https://doi.org/10.3390/jcm10051058
Chicago/Turabian Style
Rocher, Grégoire, Thomas Gaillard, Catherine Uzan, Pierre Collinet, Pierre-Adrien Bolze, Marcos Ballester, Sofiane Bendifallah, Lobna Ouldamer, Cyril Touboul, Cyrille Huchon,
and et al. 2021. "Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group" Journal of Clinical Medicine 10, no. 5: 1058.
https://doi.org/10.3390/jcm10051058
APA Style
Rocher, G., Gaillard, T., Uzan, C., Collinet, P., Bolze, P.-A., Ballester, M., Bendifallah, S., Ouldamer, L., Touboul, C., Huchon, C., Lavoue, V., Dabi, Y., Akladios, C., Coutant, C., Raimond, E., Bricou, A., Canlorbe, G., & AzaĂŻs, H.
(2021). Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group. Journal of Clinical Medicine, 10(5), 1058.
https://doi.org/10.3390/jcm10051058